Today: 3 July 2026
Browse Category

Dividends 26 September 2025 - 21 October 2025

HeartCore (HTCR) Stock Soars on Dividend Surprise – Analysts Weigh In

HeartCore (HTCR) Stock Soars on Dividend Surprise – Analysts Weigh In

HTCR’s stock surged on Oct. 20, 2025, when the company revealed the $0.13/share dividend globenewswire.com. In after-hours trading, the share price jumped roughly 40% investing.com. By Oct. 21, HTCR traded around $0.71 reuters.com. The stock’s 52-week range is $0.39–$3.38 stockanalysis.com, reflecting swings earlier this year. The dividend announcement itself was a headline event. In a GlobeNewswire release on Oct. 20, HeartCore said the one-time $0.13 payment represents ~17.8% of its Oct. 17 closing price globenewswire.com. The board approved the special dividend after reviewing the balance sheet, noting strong cash relative to debt globenewswire.com. This move was explicitly aimed at rewarding shareholders; the company said it might continue quarterly dividends in future globenewswire.com. TipRanks likewise reported that HTCR declared the $0.13 dividend, noting it “reflects HeartCore’s strong financial profile” and could presage regular payouts tipranks.com.
21 October 2025
··
PetroChina Stock Jumps on Oil Boom, Dividend Windfall & Stablecoin Ambitions

PetroChina Stock Jumps on Oil Boom, Dividend Windfall & Stablecoin Ambitions

PetroChina’s Hong Kong-listed H-shares have been on a notable upswing in recent months. On October 20, the stock jumped to HK$7.65, gaining +4.5% in a single session Reuters Reuters. Investors bid up the price amid a broader oil sector rally and optimism around the company’s latest moves. At current levels, PetroChina is trading near its highest price of the past year Reuters. The stock has dramatically rebounded from its 52-week low of HK$5.07 in April Reuters, reflecting improved market sentiment. Year-to-date, PetroChina’s share price is roughly flat to modestly higher, but that belies significant volatility – a mid-year surge to new highs followed by a late-summer pullback. Even so, long-term shareholders have enjoyed strong returns; PetroChina’s stock has more than tripled over the past five years, according to analysts Yahoo. With a current market capitalization around US$210 billion, PetroChina ranks among the world’s most valuable energy companies Marketscreener. Its valuation multiples remain relatively low – around 7.5 times forward earnings and ~0.8 times book value Reuters – suggesting the stock is still priced cautiously despite recent gains. Income-focused investors are particularly drawn by the rich dividend yield of about 7% Reuters, which far outstrips broader market averages.
20 October 2025
···
Texas Instruments (TXN) Stock Price Today Soars Amid Dividend Hike & AI Boom: Rally Ahead or More Pain? 🎯

Texas Instruments (TXN) Stock Price Today Soars Amid Dividend Hike & AI Boom: Rally Ahead or More Pain? 🎯

Bottom Line: Texas Instruments stock is at a crossroads in late 2025. It offers a healthy dividend, fortress financials, and industry leadership in analog chips – qualities that have long attracted value investors. Yet the stock’s recent underperformance reflects real concerns: growth has stalled post-pandemic, and the market’s hype has shifted to AI chips where TI isn’t a major player. With the share price roughly 20% off its highsstockinvest.us, the question is whether this is a breather before the next climb – or a value trap until the cycle turns. Most analysts counsel patience, essentially a “Hold”, until clearer signs of revival emergemarketbeat.com. In the meantime, investors are paid to wait and can take comfort that TI’s conservative management and broad end-market exposure position it to weather the storm. Short-term volatility is likely around the earnings release and any macro news, but barring a severe downturn, the consensus view sees moderate upside over the next year as conditions improvemarketbeat.com. For bulls, TXN represents a steady compounder poised to benefit when industrial and automotive demand inevitably pick up. For bears, the stock’s rich valuation and lack of AI exposure mean it could continue lagging flashier tech names. As Q3 results arrive,
19 October 2025
··
Truist’s Q3 Earnings Beat and 5% Dividend Yield Trigger Rally as Analysts Grow Bullish

Truist’s Q3 Earnings Beat and 5% Dividend Yield Trigger Rally as Analysts Grow Bullish

Truist’s third-quarter results breezed past expectations, providing a jolt of good news for the regional banking sector. Net income available to common shareholders came in at $1.35 billion, exceeding analysts’ $0.99 forecast investing.com and slightly above $0.99 in the prior-year quarter. Revenue of $5.24 billion was roughly in line with estimates investing.com, as strong fee-based income made up for softer interest income. “Truist delivered strong third-quarter results, underscored by robust fee income growth in investment banking and trading and wealth, healthy loan expansion, and continued expense and credit discipline,” said CEO Bill Rogers in the earnings release investing.com. Investors reacted positively. Truist’s stock jumped about 4% in pre-market trading on Oct. 17 after the results investing.com, and the rally largely held through the trading session. This bounce helped offset recent weakness in bank stocks – just a day earlier, regional banks plunged on renewed credit jitters ts2.tech. By beating forecasts and showing stable trends, Truist’s report appeared to reassure the market, bucking the pessimism that had briefly clouded the sector.
17 October 2025
···
U.S. Bancorp Stock Soars on Earnings Beat, Dividend Hike, and New Crypto Push

U.S. Bancorp Stock Soars on Earnings Beat, Dividend Hike, and New Crypto Push

U.S. Bancorp’s stock is trading around $47 per share following the earnings news, up from roughly $46 before the report. The upbeat Q3 results sparked a ~3% jump in pre-market and early session trading chartmill.com, as investors reacted to the better-than-expected profit numbers. This marks a sharp reversal of the stock’s recent trajectory – over the past month USB had slid about 6% amid market-wide volatility and rising interest rates chartmill.com. Despite today’s pop, U.S. Bancorp shares remain roughly flat year-to-date, underperforming some rival banks. For instance, Wells Fargo’s stock has surged ~27% in 2025 ts2.tech, far outpacing USB. U.S. Bancorp is still about 12% below its 52-week high and well above its spring lows near $35. The stock’s modest 2025 performance reflects earlier concerns around the banking sector – including higher deposit costs and economic uncertainty – which had weighed on regional bank valuations. However, with the latest results alleviating some fears, USB may be poised to play “catch-up” if momentum in the banking industry continues.
16 October 2025
····
BCE Stock’s Wild Ride: Dividend Drama, Bold Turnaround Plan & Analyst Predictions

BCE Stock’s Wild Ride: Dividend Drama, Bold Turnaround Plan & Analyst Predictions

As of October 14, 2025, BCE Inc.’s stock is trading around the mid-C$33 range after a period of extreme volatility. It closed at C$33.41 on the Toronto Stock Exchange, notching a slight decline on the daystockchase.com. This price marks a modest recovery from the C$28.73 low reached earlier in the year, but shares remain nearly 30% below their 12-month peak of C$46.62marketbeat.com. In other words, Bell’s stock is still deep in the hole relative to where it stood a year ago. Such turbulence reflects shifting investor reactions to recent developments. In the past week, anticipation of BCE’s Investor Day and strategic updates fueled a ~3–4% bounce in the stocksimplywall.st. Indeed, going into the investor presentations, shares had shown a “modest rebound lately, gaining 3.5% over the past week”simplywall.st as value hunters sniffed out a potential bottom. However, intraday swings on October 14 were dramatic – the stock popped above C$34 in early trading then dipped below C$32 at one point, before stabilizing around C$33 by the closestockanalysis.comstockanalysis.com. This volatility underscores the market’s uncertainty: investors are digesting both encouraging long-term plans and near-term concerns.
14 October 2025
··
CNQ Stock Skyrocketing? Oil Rally, 25-Year Dividends & Expert Forecasts (Oct 2025)

CNQ Stock Skyrocketing? Oil Rally, 25-Year Dividends & Expert Forecasts (Oct 2025)

CNQ’s stock has climbed in recent weeks. The TSX-listed share reached ~C$45.55 on Oct 9simplywall.st. This is near its 3-year high, though still below the 2023 peak. Over the last week it gained ~3%simplywall.st, driven by a bounce in oil prices and positive sentiment. For context, CNQ is up ~45% over 3 years and nearly +400% over 5 yearssimplywall.st, illustrating its strong long-term return. In intraday action on Oct 10, CNQ did fall on heavy volume, partly reflecting a broad market selloffoilprice.comand some specific worries. However, analysts note this pullback may be driven by macro jitters rather than company fundamentals. Overall sentiment remains cautiously bullish: Simply Wall St calls CNQ undervalued and notes the stock is “trading at nearly a 70% discount” to intrinsic valuesimplywall.st.
11 October 2025
··
3M Stock Set to Soar! PFAS Settlement and Dividends Spark Rally (Oct 2025)

3M Stock Set to Soar! PFAS Settlement and Dividends Spark Rally (Oct 2025)

3M’s stock has been trading in the low-to-mid $150s this autumn. As of Oct 10, 2025, it closed near $148.75tradingview.com. That day’s drop came amid broad market pullback. Over the past week MMM has slid roughly –6.4%tradingview.com, reversing part of its earlier gains. The 52-week trading range is about $122–$164, with 50-day and 200-day moving averages near $154 and $149 respectivelymarketbeat.com. Technical indicators show MMM recently lost some momentum. Chart analysis highlights a support zone around $146–147 and resistance near $156–167. For example, AI-driven signals mark current support ≈$146.6 and resistance at $156.8 and $166.7news.stocktradersdaily.com. An embedded chart illustrates MMM’s price relative to these support and resistance levels:
11 October 2025
··
Tesco Shares Soar After Double‑Digit Dividend Hike: What Investors Need to Know

Tesco Shares Soar After Double‑Digit Dividend Hike: What Investors Need to Know

Tesco’s half‑year results highlight how the UK’s largest grocer continues to grow despite intense competition from German discounters Aldi and Lidl. Group sales climbed 5.1% to £33 billion while adjusted operating profit edged up 1.5% directorstalkinterviews.com. Chief executive Ken Murphy said the business grew sales in each of its divisions and achieved market‑share gains by “investing significantly in value, quality and service” and through “early, disciplined and targeted” savings to offset cost inflation directorstalkinterviews.com. Price perception is a critical battleground in UK grocery. Tesco’s “Aldi Price Match” and Clubcard Prices schemes allowed it to sharpen pricing while retaining margins. Its loyalty‑card analytics have become a powerful tool: the Clubcard program is used by around 21 million UK households and provides personalised offers that drive repeat shopping. Murphy highlighted that Tesco’s price position versus the market is now more than 300 basis points better than two years ago directorstalkinterviews.com, while customer satisfaction scores and brand perception have improved. These metrics illustrate how investment in data‑driven promotions can yield market‑share gains even in a low‑growth environment.
2 October 2025
··
Pfizer Stock 2025: 7% Dividend, Obesity Gamble, and Wall Street’s Verdict

Pfizer Stock 2025: 7% Dividend, Obesity Gamble, and Wall Street’s Verdict

Pfizer’s stock has struggled in 2025, hovering near multi-year lows. At ~$23.60 per share in late September, PFE has declined about 9% since January, underperforming the S&P 500 and lagging the broader healthcare sector. Over the past 12 months, the stock is down roughly 18%. The 52-week high was $30.43, and shares now sit not far above their year’s low of $20.92 stockanalysis.com. By market capitalization, Pfizer remains one of the world’s largest pharmaceutical companies, but its valuation has compressed significantly from pandemic-era peaks. This underperformance stems largely from the post-pandemic “hangover.” Pfizer’s once record-breaking COVID-19 product sales have dropped sharply, creating a tough comparison and denting investor sentiment. In 2022, Pfizer’s COVID vaccine and antiviral pill brought in a combined $37.8 billion in revenue; by 2024 that fell to $12.5 billion. Wall Street expects Pfizer’s total earnings per share to have more than halved from $6.58 in 2022 to about $3.05 in 2025. This “COVID cliff” and concerns over upcoming patent expirations have weighed heavily on the stock’s performance.
26 September 2025
···
1 … 42 43 44

Stock Market Today

  • Dave Inc. (DAVE) jumps after strong Q1, boosted forecast
    July 3, 2026, 1:39 PM EDT. Dave Inc. (DAVE) posted strong Q1 2026 results, with revenue up 47% to $158.4 million and adjusted EBITDA climbing 57% to $69.3 million. Management credited the company's short-duration credit model for driving the gains. Monthly Transacting Members and ARPU both rose, as AI-powered underwriting helped offset usual Q1 weakness. DAVE raised its full-year revenue, EBITDA, and EPS guidance for the eighth quarter in a row. The stock is getting support from better credit performance, removal of fee caps, and more liquidity thanks to a deal with Coastal Community Bank. DAVE, holding a Zacks Rank #1 (Strong Buy), has seen 2026 and 2027 EPS estimates move up. Shares are up 27.1% in three months, tracking ahead of the industry. There's still some risk from regulation and credit, but the company continues to execute on growth.
Go toTop